Categories
- All
- Animal & Veterinary
- Award
- Biologics
- Coronavirus
- Cosmetics
- Design
- Dietary Supplements
- Drugs
- Follow @FDAmedia on Twitter
- Follow @FDAMedia on X
- Follow @US_FDA on Twitter
- Follow @US_FDA on X
- Follow FDA on Facebook
- Food & Beverages
- Healthy
- Hotel
- Infant Formula & Foods
- Infectious Disease
- Lifestyle
- Medical Devices
- Nature
- Office
- Over-the-Counter Drugs
- Tobacco
- Training
- Travel Tips
- Travel Tips
- Vaccines
Filter Articles
Search by title or filter by category
911 articles found
-
Coronavirus (COVID-19) Update: September 7, 2021The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:As part of the FDA’s effort to protect consumers, the agency i... -
FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug ApprovalsThe following quote is attributed to Sally Choe, Ph.D., director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research “This week, the FDA reached the mileston...
-
FDA In Brief: FDA to Hold Advisory Committee Meeting to Discuss Pfizer-BioNTech’s Application for COVID-19 BoosterThe following quote is attributed to Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Research and Evaluation: “The administration recently announced a plan to prepare f...
-
Coronavirus (COVID-19) Update: August 31, 2021The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:On August 27, the FDA made changes to the authorized use of th...
-
Coronavirus (COVID-19) Update: August 27, 2021The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:On August 25, the FDA issued a Letter to Health Care Providers...
-
FDA Approves First-of-Its-Kind Stroke Rehabilitation SystemThe U.S. Food and Drug Administration today approved the MicroTransponder Vivistim Paired VNS System (Vivistim System), a first-of-its-kind, drug-free rehabilitation system intended to treat moderate...
-
FDA Denies Marketing Applications for About 55,000 Flavored E-Cigarette Products for Failing to Provide Evidence They Appropriately Protect Public HealthToday, the U.S. Food and Drug Administration issued the first marketing denial orders (MDOs) for electronic nicotine delivery system (ENDS) products after determining the applications for about 55,000...
-
FDA Releases PFAS Testing Results from First Survey of Nationally Distributed Processed FoodsToday, the U.S. Food and Drug Administration released the results of the first survey of per- and polyfluoroalkyl substances (PFAS) in nationally distributed processed foods, including several process...
-
Coronavirus (COVID-19) Update: August 24, 2021The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:On Aug. 22, the FDA updated the Pfizer-BioNTech emergency use...
-
FDA and Mexican Counterparts Report Progress and Next Steps for Food Safety PartnershipAs part of our ongoing efforts to ensure the safety of food imported from Mexico and advance protections for consumers in both countries, the U.S. Food and Drug Administration and its regulatory count...